Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)

China flag China · Delayed Price · Currency is CNY
30.41
+0.55 (1.84%)
Mar 10, 2026, 3:00 PM CST
34.02%
Market Cap 6.06B
Revenue (ttm) 964.93M
Net Income (ttm) 258.67M
Shares Out 199.43M
EPS (ttm) 1.30
PE Ratio 23.39
Forward PE n/a
Dividend 0.78 (2.61%)
Ex-Dividend Date Sep 17, 2025
Volume 2,996,997
Average Volume 1,827,175
Open 29.76
Previous Close 29.86
Day's Range 29.76 - 30.58
52-Week Range 20.77 - 44.68
Beta 0.61
RSI 61.24
Earnings Date Apr 28, 2026

About SHA:688566

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company’s products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in table... [Read more]

Sector Healthcare
Founded 2001
Employees 1,326
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688566
Full Company Profile

Financial Performance

In 2025, SHA:688566's revenue was 964.93 million, an increase of 7.63% compared to the previous year's 896.53 million. Earnings were 258.67 million, an increase of 17.94%.

Financial Statements

News

There is no news available yet.